OPKO Health EBITDA Margin 2011-2025 | OPK
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for OPKO Health (OPK) over the last 10 years. The current EBITDA margin for OPKO Health as of September 30, 2025 is .
| OPKO Health EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $0.64B | $-0.01B | -1.87% |
| 2025-06-30 | $0.67B | $-0.04B | -6.62% |
| 2025-03-31 | $0.69B | $-0.05B | -7.10% |
| 2024-12-31 | $0.71B | $-0.05B | -7.14% |
| 2024-09-30 | $0.71B | $-0.09B | -12.08% |
| 2024-06-30 | $0.72B | $-0.16B | -22.73% |
| 2024-03-31 | $0.80B | $-0.09B | -11.50% |
| 2023-12-31 | $0.86B | $-0.05B | -5.90% |
| 2023-09-30 | $0.87B | $-0.04B | -4.27% |
| 2023-06-30 | $0.87B | $-0.06B | -6.91% |
| 2023-03-31 | $0.91B | $-0.08B | -8.32% |
| 2022-12-31 | $1.00B | $-0.12B | -11.55% |
| 2022-09-30 | $1.22B | $-0.13B | -10.74% |
| 2022-06-30 | $1.43B | $-0.01B | -0.91% |
| 2022-03-31 | $1.56B | $0.00B | -0.32% |
| 2021-12-31 | $1.77B | $0.10B | 5.52% |
| 2021-09-30 | $1.87B | $0.21B | 11.35% |
| 2021-06-30 | $1.91B | $0.20B | 10.37% |
| 2021-03-31 | $1.77B | $0.22B | 12.55% |
| 2020-12-31 | $1.44B | $0.14B | 10.03% |
| 2020-09-30 | $1.16B | $-0.02B | -1.29% |
| 2020-06-30 | $0.97B | $-0.07B | -7.56% |
| 2020-03-31 | $0.89B | $-0.15B | -16.52% |
| 2019-12-31 | $0.90B | $-0.18B | -19.87% |
| 2019-09-30 | $0.90B | $-0.16B | -17.35% |
| 2019-06-30 | $0.92B | $-0.15B | -16.30% |
| 2019-03-31 | $0.96B | $-0.11B | -11.06% |
| 2018-12-31 | $0.99B | $-0.07B | -7.37% |
| 2018-09-30 | $0.93B | $-0.14B | -14.95% |
| 2018-06-30 | $0.93B | $-0.15B | -16.41% |
| 2018-03-31 | $0.96B | $-0.17B | -18.01% |
| 2017-12-31 | $0.97B | $-0.17B | -17.91% |
| 2017-09-30 | $0.98B | $-0.09B | -9.32% |
| 2017-06-30 | $1.03B | $-0.07B | -6.52% |
| 2017-03-31 | $1.09B | $-0.01B | -1.28% |
| 2016-12-31 | $1.12B | 0 | 0.00% |
| 2016-09-30 | $1.22B | $0.06B | 5.24% |
| 2016-06-30 | $1.07B | $0.07B | 6.19% |
| 2016-03-31 | $0.75B | $-0.01B | -1.06% |
| 2015-12-31 | $0.49B | $-0.06B | -11.41% |
| 2015-09-30 | $0.24B | $-0.10B | -41.08% |
| 2015-06-30 | $0.12B | $-0.15B | -124.58% |
| 2015-03-31 | $0.10B | $-0.16B | -155.00% |
| 2014-12-31 | $0.09B | $-0.13B | -140.22% |
| 2014-09-30 | $0.09B | $-0.13B | -150.57% |
| 2014-06-30 | $0.09B | $-0.10B | -115.91% |
| 2014-03-31 | $0.09B | $-0.09B | -98.86% |
| 2013-12-31 | $0.10B | $-0.06B | -64.95% |
| 2013-09-30 | $0.09B | $-0.04B | -42.39% |
| 2013-06-30 | $0.08B | $-0.03B | -37.35% |
| 2013-03-31 | $0.07B | $-0.02B | -34.78% |
| 2012-12-31 | $0.05B | $-0.03B | -59.57% |
| 2012-09-30 | $0.04B | $-0.03B | -78.38% |
| 2012-06-30 | $0.03B | $-0.03B | -84.38% |
| 2012-03-31 | $0.03B | $-0.02B | -80.00% |
| 2011-12-31 | $0.03B | $-0.02B | -71.43% |
| 2011-09-30 | $0.03B | $-0.01B | -31.03% |
| 2011-06-30 | $0.03B | $-0.01B | -28.57% |
| 2011-03-31 | $0.03B | $-0.01B | -33.33% |
| 2010-12-31 | $0.03B | $-0.01B | -32.14% |
| 2010-09-30 | $0.02B | $-0.02B | -78.95% |
| 2010-06-30 | $0.02B | $-0.02B | -106.67% |
| 2010-03-31 | $0.01B | $-0.02B | -160.00% |
| 2009-12-31 | $0.00B | $-0.02B | -525.00% |
| 2009-09-30 | $0.01B | $-0.03B | -337.50% |
| 2009-06-30 | $0.01B | $-0.03B | -300.00% |
| 2009-03-31 | $0.01B | $-0.04B | -388.89% |
| 2008-12-31 | $0.01B | $-0.04B | -370.00% |
| 2003-03-31 | $0.00B | $-0.01B | 0.00% |
| 2002-12-31 | $0.00B | $-0.01B | 0.00% |
| 2002-06-30 | $0.00B | $-0.01B | 0.00% |
| 2002-03-31 | $0.00B | $-0.01B | 0.00% |
| 2001-12-31 | $0.00B | $-0.01B | 0.00% |
| 2001-09-30 | $0.00B | $-0.01B | 0.00% |
| 2001-06-30 | $0.00B | $-0.01B | 0.00% |
| 2001-03-31 | $0.00B | $-0.01B | 0.00% |
| 2000-12-31 | $0.00B | $-0.01B | 0.00% |
| 2000-09-30 | $0.00B | $-0.01B | -700.00% |
| 2000-06-30 | $0.00B | $-0.01B | -600.00% |
| 2000-03-31 | $0.00B | $-0.01B | -500.00% |
| 1999-12-31 | $0.00B | $0.00B | -400.00% |
| 1999-09-30 | $0.00B | $0.00B | 0.00% |
| 1999-06-30 | $0.00B | $0.00B | 0.00% |
| 1999-03-31 | $0.00B | $0.00B | -300.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.013B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $220.924B | 26.25 |
| Intuitive Surgical (ISRG) | United States | $205.210B | 80.29 |
| IDEXX Laboratories (IDXX) | United States | $56.979B | 56.59 |
| Edwards Lifesciences (EW) | United States | $49.662B | 33.30 |
| Alcon (ALC) | Switzerland | $39.183B | 26.48 |
| IQVIA Holdings (IQV) | United States | $37.616B | 20.98 |
| Mettler-Toledo (MTD) | United States | $29.577B | 34.60 |
| STERIS (STE) | Ireland | $26.302B | 27.15 |
| DexCom (DXCM) | United States | $23.249B | 32.05 |
| Waters (WAT) | United States | $23.062B | 30.50 |
| Hologic (HOLX) | United States | $16.584B | 17.46 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.430B | 0.00 |
| Globus Medical (GMED) | United States | $11.441B | 23.80 |
| Penumbra (PEN) | United States | $10.977B | 77.21 |
| Masimo (MASI) | United States | $8.046B | 25.78 |
| Sysmex ADR (SSMXY) | Japan | $6.553B | 20.82 |
| Glaukos (GKOS) | United States | $5.319B | 0.00 |
| Teleflex (TFX) | United States | $4.927B | 7.85 |
| TransMedics (TMDX) | United States | $4.073B | 48.25 |
| Veracyte (VCYT) | United States | $3.344B | 38.11 |
| LivaNova (LIVN) | United Kingdom | $3.092B | 16.70 |
| Alphatec Holdings (ATEC) | United States | $3.082B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.436B | 11.43 |
| Artivion (AORT) | United States | $2.256B | 103.54 |
| Nihon Kohden (NHNKY) | Japan | $1.858B | 16.22 |
| Elekta AB (EKTAY) | Sweden | $1.739B | 16.85 |
| PROCEPT BioRobotics (PRCT) | United States | $1.719B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.240B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.225B | 0.00 |
| AxoGen (AXGN) | United States | $1.111B | 0.00 |
| IRadimed (IRMD) | United States | $1.099B | 52.38 |
| Pulse Biosciences (PLSE) | United States | $1.017B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.942B | 5.10 |
| SiBone (SIBN) | United States | $0.781B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.604B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.549B | 31.93 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.546B | 10.89 |
| Pacific Biosciences Of California (PACB) | United States | $0.525B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.522B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.475B | 0.00 |
| NeuroPace (NPCE) | United States | $0.450B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.441B | 12.18 |
| OrthoPediatrics (KIDS) | United States | $0.426B | 0.00 |
| RxSight (RXST) | United States | $0.412B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.408B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.390B | 2.94 |
| Alpha Tau Medical (DRTS) | Israel | $0.337B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.303B | 50.53 |
| Spectral Diagnostics (EDTXF) | Canada | $0.298B | 0.00 |
| CVRx (CVRX) | United States | $0.250B | 0.00 |
| 908 Devices (MASS) | United States | $0.214B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.212B | 0.00 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.183B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.149B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.148B | 0.00 |
| Neuronetics (STIM) | United States | $0.148B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.142B | 0.00 |
| Accuray (ARAY) | United States | $0.134B | 0.00 |
| LENSAR (LNSR) | United States | $0.124B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.075B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Spectral AI (MDAI) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.025B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.51 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |